添加生物公司

SecurityACET / Adicet Bio, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership38,368 shares
Latest Disclosed Value $ 261,286
UBS Group AG reports 910.48% increase in ownership of ACET / Adicet Bio, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 38,368 shares of Adicet Bio, Inc. (US:ACET) valued at $261,286 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 3,797 shares of Adicet Bio, Inc.. This represents a change in shares of 910.48% during the quarter. The current value of the position is $312,699 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ADICET BIO COM NEW 007002207 38,368 34,571 910.48 261 741.94 0.0000
2026-01-29 2025-12-31 13F ADICET BIO COM NEW 007002207 3,797 32
2020-07-31 2020-06-30 13F RESTORBIO COM 76133L103 9,362 5,275 129.07 20 400.00 0.0000
2020-05-01 2020-03-31 13F RESTORBIO COM 76133L103 4,087 -611,880 -99.34 4 -99.56 0.0000
2020-02-14 2019-12-31 13F RESTORBIO COM 76133L103 615,967 608,462 8,107.42 918 1,270.15 0.0003
2019-11-14 2019-09-30 13F RESTORBIO COM 76133L103 7,505 7,005 1,401.00 67 1,240.00 0.0000
2019-08-14 2019-06-30 13F RESTORBIO COM 76133L103 500 -1,300 -72.22 5 -58.33 0.0000
2019-05-14 2019-03-31 13F RESTORBIO COM 76133L103 1,800 -847 -32.00 12 -47.83 0.0000
2019-02-14 2018-12-31 13F RESTORBIO COM 76133L103 2,647 331 14.29 23 -34.29 0.0000
2018-11-14 2018-09-30 13F RESTORBIO COM 76133L103 2,316 773 50.10 35 150.00 0.0000
2018-08-14 2018-06-30 13F RESTORBIO COM 76133L103 1,543 1,543 14 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.